Hackensack Meridian Health, 92 Second Street — Hackensack, New Jersey

Hackensack Meridian Health, 92 Second Street is a clinical research site located in Hackensack, New Jersey, United States 07601.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

Hackensack Meridian Health, 92 Second Street has participated in 1 clinical trials.

Therapeutic areas: Glioblastoma Multiforme.

Sponsors: Karyopharm Therapeutics Inc.

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Hackensack Meridian Health, 92 Second Street?

Hackensack Meridian Health, 92 Second Street has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Hackensack Meridian Health, 92 Second Street conducted?

Hackensack Meridian Health, 92 Second Street has 1 clinical trials on record. Their work covers Glioblastoma Multiforme.

Is Hackensack Meridian Health, 92 Second Street accredited by Crixeo Health?

Hackensack Meridian Health, 92 Second Street has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Hackensack Meridian Health, 92 Second Street?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.